Home > Boards > US OTC > Miscellaneous >

Axim Biotechnologies Inc. (AXIM)

Add AXIM Price Alert      Hide Sticky   Hide Intro
Moderator: Ecostate, StockRoomBully
Search This Board: 
Last Post: 9/20/2020 10:58:58 PM - Followers: 96 - Board type: Free - Posts Today: 0

News updates July 23rd 2020
"The NeuCovix™ test was compared to a gold standard pseudovirus-based test. NeuCovix™ accurately classified serum from patients who strongly neutralized SARS-CoV-2 and serum from patients who poorly neutralized the virus. Additionally, NeuCovix™ did not cross-react with serum from patients with seasonal respiratory infections including seasonal coronaviruses, suggesting that the test has 100 percent specificity for COVID-19. 


July 15, 2020 08:30 ET Source: AXIM BIOTECHNOLOGIES, INC
SAN DIEGO, July 15, 2020 (GLOBE NEWSWIRE) -- AXIM® Biotechnologies, Inc. (OTCQB: AXIM) (“AXIM® Biotech,” “AXIM” or “the Company”), an international healthcare solutions company targeting oncological research, today announced the development of NeuCovixTM, a rapid diagnostic test measuring levels of functional neutralizing antibodies that are believed to prevent SARS-CoV-2 from entering the host cells.

Unlike currently available serological COVID-19 tests that detect an antibody response to the virus, AXIM’s rapid 10-minute test measures a specific subpopulation of antibodies to block binding of the virus to host cell receptors. While there are expensive, time consuming laboratory tests that measure neutralizing antibodies, NeuCovixTM differs in that it is a portable, low cost, rapid point-of-care test with results in 10 minutes.

“We are hopeful our test fills an important need in these uncertain times. While other tests merely show whether someone was infected with coronavirus, we took it a step further by creating a test that stratifies individuals into those who have neutralizing antibodies, which are essential in preventing reinfection, and those who don’t. The test can be deployed for point of care use in convalescent plasma transfusions to severely ill patients and for evaluating efficacy of upcoming vaccines in generating protective antibodies,” said Sergei Svarovsky, PhD, MBA, AXIM’s CSO and co-inventor of NeuCovixTM.

An immediate application of NeuCovixTM, a point-of-care test, is to measure levels of neutralizing antibodies in convalescent plasma so that plasma with the highest levels of neutralizing antibodies can be identified and administered to patients fighting COVID-19.  Without this knowledge, many patients could be undertreated with non-neutralizing plasma and may not benefit from this treatment. 

Another application of NeuCovixTM is to help ensure that vaccines elicit high levels of neutralizing antibodies. When a vaccine is available, manufacturers can employ the NeuCovixTM rapid, point-of-care test to evaluate protective immune responses in vaccine recipients.

AXIM® Biotech CEO John W. Huemoeller II commented, Our goal was to make this test, accurate, fast and relatively inexpensive so it could serve as an ‘Immunity Passport port™’ for vaccine developers around the world as they begin larger Phase II and III clinical trials. We are optimistic that NeuCovixTM will be widely used, becoming the gold standard in assessing levels of immunity.

Doug Lake, Ph.D. and co-inventor of NeuCovixTM commented, “Everybody who recovers from COVID-19 makes antibodies against the virus, but since all antibodies are not created equal, you really want to know if the antibodies you make neutralize the virus. People who recover want to make sure they are protected from re-infection and that they won’t infect others.”

AXIM also announced the filing of a pre-Emergency Use Authorization Application (EUA) and has already initiated dialogue with the FDA in order to finalize its EUA submission. The intellectual property relating to the novel serological test is the subject of Provisional Patent Application No. 63/023,646 “Convalescent Plasma Testing and Treatment” filed on May 12, 2020. 

About AXIM® Biotechnologies
Founded in 2014, AXIM® Biotechnologies, Inc. (AXIM) is a vertically integrated oncology company developing rapid diagnostic tests for the early detection of cancer and proprietary small molecules drugs to treat cancer and block metastasis. The Company is also developing novel antibodies for therapeutic and diagnostic uses for oncological therapeutics. For more information, please visit www.AXIMBiotech.com.



Current Price
Bid Ask Day's Range
  • 1D
  • 1M
  • 2M
  • 3M
  • 6M
  • 1Y
  • 2Y
  • 3Y
  • 5Y
#1008  Sticky Note $Axim NeuCovix TM vs Current rapid test Highlights: StockRoomBully 07/15/20 04:57:54 PM
#1308   The weekly chart tells the story baldingcontrarian 09/20/20 10:58:58 PM
#1307   Hope so. Those 20k shares I nabbed at Insightfulpenguin 09/16/20 01:51:36 PM
#1306   Isn't this old news? I thought they had imjake 09/16/20 12:36:03 PM
#1305   It gapped up, so MMs had to bring nilremerlin 09/16/20 12:35:17 PM
#1304   Well that share price action didn’t last long. Insightfulpenguin 09/16/20 10:27:09 AM
#1303   Like Mr Wonderful, baldingcontrarian 09/16/20 09:45:27 AM
#1302   There is nothing to Lol about i’m in Fred619 09/16/20 09:42:34 AM
#1301   Lol Can't believe you said that. LoL Dean14 09/16/20 09:41:12 AM
#1300   They can sell that’s great but FDA can Fred619 09/16/20 09:31:06 AM
#1299   Read the news Last month, AXIM signed Dean14 09/16/20 09:27:22 AM
#1298   How many times they going to file. Lol Fred619 09/16/20 09:26:14 AM
#1297   They can start selling NOW. AXIM casaprop 09/16/20 09:21:51 AM
#1296   AXIM(R) Biotechnologies Files Emergency Use Authorization With the Dean14 09/16/20 09:18:40 AM
#1295   Azar is out to screw us all: nilremerlin 09/15/20 08:28:52 PM
#1294   Time is running out baldingcontrarian 09/15/20 02:57:15 PM
#1293   Picked some low-hanging shares at .57975 this morning nilremerlin 09/15/20 01:41:23 PM
#1292   People are forgeting that many republican US senators Potguy2030 09/12/20 12:59:40 PM
#1291   The chart says dollars incoming baldingcontrarian 09/12/20 12:20:58 PM
#1290   The chart says dollars incoming baldingcontrarian 09/12/20 12:15:54 PM
#1289   Looking back - baldingcontrarian 09/12/20 01:20:46 AM
#1288   By looking at AXIM's stock chart. I see scoobey-do 09/11/20 05:59:32 PM
#1287   Aggressive buyer today. baldingcontrarian 09/11/20 04:47:16 PM
#1286   What other competitors might also have a Covid-19 BesaoT35 09/03/20 12:32:58 PM
#1285   We will go from obscurity to the belle baldingcontrarian 08/30/20 12:07:31 AM
#1284   Sure hope this is the week we have Dean14 08/29/20 12:07:19 PM
#1283   Started a position here this morning. Looking for 737Flyer 08/25/20 10:26:15 AM
#1282   In a separate transaction, Conte and Ahearn successfully Dean14 08/25/20 10:24:12 AM
#1281   Very interesting. Thank you subslover 08/25/20 08:20:06 AM
#1280   Owner of WellWay https://www.linkedin.com/in/rickhennessey ScooterTime022 08/25/20 01:08:04 AM
#1279   Wellway Diagnostics LLC Dean14 08/24/20 11:36:44 AM
#1278   TRU-19™ trademark registration is intended to cover the Dean14 08/24/20 11:29:19 AM
#1277   Good for them. Until this location address get StockRoomBully 08/24/20 10:19:38 AM
#1276   We know mission statement Mr Hennessey own the StockRoomBully 08/24/20 10:18:11 AM
#1275   Someone likes AXIM's news, AXIM is up 24% scoobey-do 08/24/20 10:09:44 AM
#1274   Empowered Diagnostics' Mission Statement: scoobey-do 08/24/20 10:03:53 AM
#1273   Bro they on sunbiz StockRoomBully 08/24/20 09:49:29 AM
#1272   Big on this but something doesnt ad up. StockRoomBully 08/24/20 09:49:01 AM
#1271   Here is a more complete PR: scoobey-do 08/24/20 09:48:56 AM
#1270   Hate to say it, but I can't find scoobey-do 08/24/20 09:45:52 AM
#1269   FYI Empowered diagnostic seem fishy. No address see StockRoomBully 08/24/20 09:23:05 AM
#1268   Axim Bio inks manufacturing deal for COVID-19 antibody test scoobey-do 08/24/20 09:20:04 AM
#1266   FDA is supposed to respond to the company x100xPercent 08/19/20 07:30:57 PM
#1265   Because they are not on a set schedule Buddy124 08/19/20 06:44:30 PM
#1264   How do u calculate that this week is Buddy124 08/19/20 06:38:53 PM
#1263   I'm in today at .719, last trade of nilremerlin 08/19/20 05:05:58 PM
#1262   Should be getting an update on that EUA x100xPercent 08/19/20 04:29:59 PM
#1261   From an adjustment not operations... baldingcontrarian 08/15/20 01:03:29 PM
#1260   https://www.otcmarkets.com/filing/conv_pdf?id=14336323&guid=yK_6UnZYzV0m0yh Dean14 08/15/20 09:22:05 AM
#1259   10q out. Almost no loss this quarter, first x100xPercent 08/14/20 04:12:09 PM
#1258   Sapphire Biotech, Subsidiary of AXIM® Biotechnologies, Awarded Prestigious scoobey-do 08/14/20 03:13:24 PM
Consent Preferences